Influx Healthtech IPO GMP & Review: Apply or Avoid?

Influx Healthtech IPO is open for bidding on 18th June 2025. It is a bookbuilding IPO that comprises a fresh issue of 50.00 lakh shares worth ₹48.00 crores and an offer for sale of 11.00 lakh shares worth ₹10.56 crores. The issue will be listed on NSE and SME on its tentative listing date, 25th June 2025. 

Influx Healthtech IPO Details 

Influx Healthtech IPO date is fixed between 18th June 2025 and 20th June 2025. The face value of Influx Healthtech Limited shares stands at ₹10 per share, and the IPO price band is fixed at ₹91 to ₹96 per share. 

Maashitla Securities Private Limited is the registrar of the Influx Healthtech IPO and is responsible for managing the allotment process and initiating refunds. Check out the latest IPO details in the table below. 

Influx Healthtech IPO Share Reservation

Influx Healthtech IPO is a bookbuilding IPO issue of 61.00 lakh shares worth ₹58.57 crores. Influx Healthtech Limited shares will be listed on the NSE and SME. Furthermore, SEBI has specified the share reservation criteria for different investor categories. 

Influx Healthtech IPO GMP Grey Market Premium

GMP is the gap between the price band of the issue and the price at which company shares are currently trading in the grey market. Do you want to get live updates on Influx Healthtech IPO GMP? If yes, then you’ve reached the right spot. Check the table below to learn about the GMP trends.

As of 17th June 2025, Influx Healthtech IPO GMP stands at ₹35 per share, which means the share will likely show a listing at ₹131 (96+35) on its tentative listing date, 25th June 2025.

GMP data is subject to change based on market trends and sentiments. You should check the live GMP status before applying for the Influx Healthtech IPO. Stay informed with Univest to know about real-time insights on IPOs and their GMP trends. 

Influx Healthtech IPO Review

Check out the detailed Influx Healthtech IPO review for a thorough understanding of its potential to report listing gains on 24th June 2025. The Influx Healthtech IPO review below will help you invest effectively to avoid significant losses. Explore more to make informed investment decisions on this IPO. 

Financial Health

Assess a company’s financial performance to know about its ability to sustain a competitive edge. Thus, it is essential to understand the growth margins and declines of the business financials before applying for the Influx Healthtech IPO.

Influx Healthtech Limited’s revenue rose 4.88% from ₹100.10 crores in March 2024 to ₹104.99 crores in March 2025. Moreover, the company’s PAT decreased by 19.16% from ₹11.22 crores to ₹13.37 crores. 

Influx Healthtech Limited has shown consistent revenue growth, indicating that the company is financially stable. Moreover, the brokers, investors, and RAs have a positive outlook for the Influx Healthtech IPO for its tentative listing day, which is 25th June 2025.  

Technical Analysis

A number of technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technicals of the Influx Healthtech IPO.

The PE ratio of Influx Healthtech Limited shares is 13.04, and its Earnings Per Share (EPS) stands at 7.36. The Influx Healthtech IPO can potentially deliver gains on its tentative listing date, 25th June 2025. 

Influx Healthtech Limited Peer Comparison

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Influx Healthtech Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics. 

Influx Healthtech IPO Subscription Status

Influx Healthtech IPO is now open for bidding on 18th June 2025. The subscription status for this IPO is yet to be announced. Stay informed on this passage to check the live Influx Healthtech IPO Subscription Status. 

About Influx Healthtech Limited

Influx Healthtech Limited was incorporated in 2020 and is a healthcare-focused company specialising in contract manufacturing. The product portfolio of Influx Healthtech Limited includes Tablets, Capsules, Powders, Softgels, Face Masks, Soaps, Homecare Solutions, Skincare Items, Hair Care Items, etc. It aids Nutraceutical and Cosmetic firms with product development and manufacturing techniques. Here are the major competitive strengths of Influx Healthtech Limited. 

• Diverse Clientele
• Diverse Product Portfolio
• Experienced Management and Promoters
• Quality Assurance and Control

Influx Healthtech Limited Financials

The company’s financial analysis is essential before applying for the Influx Healthtech IPO. Look at the table to learn about Eppeltone Engineers Limited’s financials. 

Explanation

Influx Healthtech Limited’s revenue rose 4.88% from ₹100.10 crores in March 2024 to ₹104.99 crores in March 2025. Moreover, the company’s PAT decreased by 19.16% from ₹11.22 crores to ₹13.37 crores. 

Influx Healthtech IPO Bidding Requirements

Influx Healthtech IPO has reserved lot sizes to be applied by different investor categories. Look at the table below to know about the requirements to be fulfilled for applying for this IPO. 

Use the lot size calculator to find how many shares you should apply!

Influx Healthtech IPO Promoter Holdings

Have a look at the table below to check the holdings of Influx Healthtech Limited’s promoters: Shirin Munir Ahmed Chandniwala and Mr. Abdul Ganee Abdul Rasul Chandniwala. 

Note: Promoter Holdings’ value is to be calculated using Equity dilution, which represents the gap between shareholdings before and after the Issue. 

Aim of Influx Healthtech IPO

The primary aim of Influx Healthtech IPO is to raise ₹58.57 crores. On the other hand, Influx Healthtech Limited has decided to utilise these funds in different practices. Explore some of the secondary objectives for Influx Healthtech IPO.

• To meet general corporate purposes. 
• To meet working capital requirements. 
• To fund the capital expenditure requirement for setting up the manufacturing facility for the Nutraceutical Division. 
• Purchase of machineries for Homecare and Cosmetic Division.

Should I Invest in the Influx Healthtech IPO?

“EEL is engaged in the manufacturing and marketing of SMPS, power conditioning devices etc. It marked growth in its top lines for the reported periods. The sudden boost in its bottom lines from FY24 onwards raise eyebrows and concern over its sustainability, as it operates in highly competitive and fragmented segment. Based on its recent financial data, the issue appears fully priced. Well-informed investors may park moderate funds for long term. ”~Dilip Davda (Chief Editor at Chittorgarh)

Explore the pros and cons of Influx Healthtech IPO to know whether you should apply or avoid the issue. These pros and cons might help you know about the IPO’s efficiency in delivering profits in the coming decades. 

Pros of Influx Healthtech IPO

• Experienced and Qualified Promoters
• Diverse and Innovative Product Portfolio

Cons of Influx Healthtech IPO

• Low Employee Base
• Low Market Capitalisation

How to Apply for Influx Healthtech IPO?

Check the steps mentioned below to apply for the Influx Healthtech IPO. 

• Step 1: Conduct thorough research on Influx Healthtech IPO GMP, subscription status, issue size, lot size, and other details. 
• Step 2: Open a demat account on Univest to learn about real-time insights on GMP and subscription status. You can also use your previous demat account by navigating to the IPO section. 
• Step 3: Make a bid for one lot of 1,200 shares worth ₹1,15,200 of Influx Healthtech IPO.   
• Step 4: You will receive a mandate request after making a bid. Approve the request to proceed further.    

Note: You can apply for the Influx Healthtech IPO from more than one demat account to increase your allotment chances. 

How to Check Influx Healthtech IPO Allotment Status?

You can check for Influx Healthtech IPO allotment in different ways. These include NSE and the registrar portal. Look at the steps mentioned below to check your allotment status online.

Check On NSE

• Visit the NSE Official Website.
• Navigate to the IPO Allotment Section. 
• Select Equity as the issue type. 
• Choose Influx Healthtech IPO.  
• Choose whether to proceed with the PAN number or the application number.
• Submit your details to get the allotment status online. 

Check On the Registrar Portal

• Visit the registrar portal. 
• Click on the allotment option.
• Fill in the required details.
• Click on the submit button to know your Influx Healthtech IPO allotment status.

Let’s Wrap

Influx Healthtech IPO is a bookbuilding issue of 61.00 lakh shares worth ₹58.57 crores. The shares of Influx Healthtech Limited will be listed on NSE and SME on its tentative listing date of 25th June 2025. Researching Influx Healthtech IPO GMP and reviews is highly suggested to book your ideal profitability. Brokers and investors have highlighted its pros and cons, so one must analyse them and decide accordingly.

Open a demat account on Univest now to initiate your investment journey!

FAQs on Influx Healthtech IPO

How is the Influx Healthtech IPO?

Ans. Currently, on 17th June 2025, Influx Healthtech IPO GMP (Grey Market Premium) stands at ₹35 (36.45% up). It indicates that the estimated listing price could be ₹131 per share.  It is a bookbuilding IPO that comprises a fresh issue of 50.00 lakh shares worth ₹48.00 crores and an offer for sale of 11.00 lakh shares worth ₹10.56 crores. The face value of each share of Influx Healthtech Limited is ₹10. 

What is the Influx Healthtech IPO price?

Ans. Influx Healthtech IPO price band has been set between ₹91 and ₹96 per share. Retail investors can apply for a minimum of 1 lot consisting of 1,200 shares worth ₹1,15,200. Moreover, HNIs are required to bid for a minimum of 2 lots (2,400 shares) worth ₹2,30,400. 

Is the Influx Healthtech IPO good?

Ans. During FY24- 25, Influx Healthtech Limited’s revenue rose 4.88% from ₹100.10 crores in March 2024 to ₹104.99 crores in March 2025. Moreover, the company’s PAT decreased by 19.16% from ₹11.22 crores to ₹13.37 crores. Investors can analyse other relevant factors and make a decision accordingly.

Who is the registrar of the Influx Healthtech IPO?

Ans. Maashitla Securities Private Limited is the registrar of Influx Healthtech IPO, awaiting to manage the IPO allotment procedure and refund initiation. For any queries regarding Influx Healthtech IPO allotment and refund, you can contact Maashitla Securities Private Limited at investor.ipo@maashitla.com or +91-11-45121795-96.

What is the issue size of the Influx Healthtech IPO? 

Ans. Influx Healthtech IPO is a bookbuilding IPO for 61.00 lakh shares worth ₹58.57 crore. Moreover, the IPO is set to open on 18th June 2025 and will be closed on 20th June 2025. 

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Influx Healthtech IPO, download the Influx Healthtech IPO RHP and Influx Healthtech IPO DRHP. Conduct your own research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.

Current & Previous IPOs

Read Our Articles on the Best Stocks

Best Shipping Stocks in India to Invest in 2025 | Shipping Sector Stocks 

Paint Stocks in India to Invest in 2025 | Paint Sector Stocks 

Paper Stocks in India to Invest in 2025 | Paper Sector Stocks 

Best Semiconductor Stocks in India 2025 

Best Large Cap Stocks in India 2025 

Green Energy Penny Stocks

Best Cement Stocks To Invest in India

What is Earnings Per Share EPS? 

Top Multibagger Penny Stocks For 2025 |  Potential Picks

Also Explore

Univest Screeners

Explore Webstories on Univest 

1. Best Time To Buy Dividend Stocks

2. How RBI Policies Affect Dividend Stocks

3. Can Dividend Stocks Beat Inflation

4. What Is The Dividend Aristocrat List

5. Which Indian Psus Offer The Best Dividends

6. Large Cap Vs Small Cap Dividend Stocks